Tobacco addiction: implications for treatment and cancer prevention.

The American Society of Clinical Oncology and the National Cancer Institute convened a symposium in June 1996 on tobacco addiction. Additional support for the symposium was provided by the American Medical Women's Association and the American Society of Preventive Oncology. The goals of this conference were to describe the burden and public health consequences of tobacco addiction, to describe the state of science for the treatment of nicotine dependence, and to explore new strategies to increase quit rates and to prevent the uptake of tobacco use. This article summarizes and integrates the meeting presentations on tobacco addiction and includes the topics of smoking prevalence; psychobiologic aspects of nicotine dependence; and implications for disease, treatment, and prevention. Comments on regulatory approaches and national strategies for reducing dependence are also summarized in presentations by Dr. David Kessler, former Food and Drug Administration Commissioner, and Dr. C. Everett Koop, former U.S. Surgeon General.

[1]  Patrick M. O'Malley,et al.  National Survey Results on Drug Use from the Monitoring the Future Study, 1975-1998. Volume I: Secondary School Students. , 1999 .

[2]  A. Graham,et al.  Principles of addiction medicine , 1998 .

[3]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[4]  S. Hecht,et al.  Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  L. Garfinkel,et al.  Trends in cigarette smoking in the United States. , 1997, Preventive medicine.

[6]  S. Hecht,et al.  Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. , 1997, Environmental health perspectives.

[7]  M. Fiore,et al.  Listening to Nicotine: Negative Affect and the Smoking Withdrawal Conundrum , 1997 .

[8]  S. Hecht,et al.  Evidence for an important role of DNA pyridyloxobutylation in rat lung carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate. , 1997, Cancer research.

[9]  P. Wingo,et al.  Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.

[10]  S. Hall,et al.  Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. , 1996, Journal of consulting and clinical psychology.

[11]  H. Bartsch,et al.  Tobacco-specific nitrosamines , 1996, European Journal of Cancer Prevention.

[12]  P. Vineis,et al.  Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  A. Garvey,et al.  Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement. , 1996, Journal of consulting and clinical psychology.

[14]  S. Hecht,et al.  Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  S. Hecht,et al.  Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  M. Spitz,et al.  Mutagen sensitivity exhibits a dose-response relationship in case-control studies. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  P. Scardino,et al.  Tobacco control: reducing cancer incidence and saving lives. American Society of Clinical Oncology. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Perkins.  Sex differences in nicotine versus nonnicotine reinforcement as determinants of tobacco smoking. , 1996 .

[19]  F P Perera,et al.  Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. , 1996, Journal of the National Cancer Institute.

[20]  S. Shiffman,et al.  First lapses to smoking: within-subjects analysis of real-time reports. , 1996, Journal of consulting and clinical psychology.

[21]  P. Cinciripini,et al.  Behavior therapy and the transdermal nicotine patch: effects on cessation outcome, affect, and coping. , 1996, Journal of consulting and clinical psychology.

[22]  E. Wynder,et al.  Differences in lung cancer risk between men and women: examination of the evidence. , 1996, Journal of the National Cancer Institute.

[23]  S. Hecht,et al.  Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. , 1996, Critical reviews in toxicology.

[24]  R Doll,et al.  Mortality from smoking worldwide. , 1996, British medical bulletin.

[25]  C. Schuster,et al.  Pharmacological aspects of drug dependence: toward an integrated neurobehavioral approach. , 1996 .

[26]  G. Connolly,et al.  Five leading U.S. commercial brands of moist snuff in 1994: assessment of carcinogenic N-nitrosamines. , 1995, Journal of the National Cancer Institute.

[27]  M. Jarvik,et al.  Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial. , 1995, Addiction.

[28]  E H Wagner,et al.  A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. , 1995, Journal of consulting and clinical psychology.

[29]  S. Hecht,et al.  Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  S. Hecht,et al.  Effects of phenethyl isothiocyanate on the tissue distribution of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites in F344 rats. , 1995, Cancer research.

[31]  J. Henningfield.  Nicotine medications for smoking cessation. , 1995, The New England journal of medicine.

[32]  S S Smith,et al.  Varying nicotine patch dose and type of smoking cessation counseling. , 1995, JAMA.

[33]  M. Spitz,et al.  Glutathione s-transferase genotypes as risk factors for head and neck cancer. , 1995, American journal of surgery.

[34]  D. Sachs.  Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high-dependent smokers. , 1995, Archives of internal medicine.

[35]  M. Spitz,et al.  Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. , 1995, Carcinogenesis.

[36]  M. Gail,et al.  Community intervention trial for smoking cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. , 1995, American journal of public health.

[37]  S. Shiffman,et al.  Nicotine withdrawal in chippers and regular smokers: subjective and cognitive effects. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[38]  P. Cinciripini,et al.  A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. , 1995, Journal of clinical psychopharmacology.

[39]  W F Velicer,et al.  An empirical typology of subjects within stage of change. , 1995, Addictive behaviors.

[40]  D. Gilbert.  Smoking : individual difference, psychopathology, and emotion , 1995 .

[41]  J. Henningfield,et al.  Estimation of available nicotine content of six smokeless tobacco products , 1995 .

[42]  M. Fiore,et al.  Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. , 1995, Mayo Clinic proceedings.

[43]  M. Spitz,et al.  Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[44]  I. Stolerman,et al.  Nicotine psychopharmacology: Addiction, cognition and neuroadaptation , 1995, Medicinal research reviews.

[45]  Mitchell H. Gail,et al.  Community Intervention Trial for Smoking Cessation (COMMIT): I. cohort results from a four-year community intervention. , 1995, American journal of public health.

[46]  A. Copeland,et al.  Programmed therapeutic messages as a smoking treatment adjunct: reducing the impact of negative affect. , 1995, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[47]  P. G. Tee,et al.  Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. , 1995, Journal of the National Cancer Institute. Monographs.

[48]  M. Fiore,et al.  The Effectiveness of the Nicotine Patch for Smoking Cessation , 1994 .

[49]  D. Wetter,et al.  Smoking outcome expectancies: factor structure, predictive validity, and discriminant validity. , 1994, Journal of abnormal psychology.

[50]  M. Spitz,et al.  Epidemiology, biology, and chemoprevention of aerodigestive cancer , 1994, Cancer.

[51]  R. Peto,et al.  Smoking and death: the past 40 years and the next 40 , 1994, BMJ.

[52]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[53]  V. Strecher,et al.  The effects of computer-tailored smoking cessation messages in family practice settings. , 1994, The Journal of family practice.

[54]  L. Kozlowski,et al.  A proposal to develop meaningful labeling for cigarettes. , 1994, JAMA.

[55]  E. Levin,et al.  Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone , 1994, Clinical pharmacology and therapeutics.

[56]  I. Anderson,et al.  The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants , 1994, Journal of psychopharmacology.

[57]  M. Fiore,et al.  The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. , 1994, JAMA.

[58]  D. Hatsukami,et al.  Pharmacodynamic effects of cotinine in abstinent cigarette smokers , 1994, Clinical pharmacology and therapeutics.

[59]  S S Smith,et al.  Predicting smoking cessation. Who will quit with and without the nicotine patch. , 1994, JAMA.

[60]  S. Hall,et al.  Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. , 1994, Journal of consulting and clinical psychology.

[61]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[62]  Cigarette smoking among adults--United States, 1993. , 1994, MMWR. Morbidity and mortality weekly report.

[63]  A. Dipple.  Reactions of polycyclic aromatic hydrocarbons with DNA. , 1994, IARC scientific publications.

[64]  R. Kessler,et al.  Comparative Epidemiology of Dependence on Tobacco , Alcohol , Controlled Substances , and Inhalants : Basic Findings From the National Comorbidity Survey , 1994 .

[65]  J. Horm,et al.  Negative moods as correlates of smoking and heavier drinking: implications for health promotion. , 1993, Advance data.

[66]  D. Hatsukami,et al.  Effects of tobacco abstinence on food intake among cigarette smokers. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[67]  A. C. Collins,et al.  Why some people smoke and others do not: new perspectives. , 1993, Journal of consulting and clinical psychology.

[68]  A. Cepeda-Benito,et al.  Meta-analytical review of the efficacy of nicotine chewing gum in smoking treatment programs. , 1993, Journal of consulting and clinical psychology.

[69]  R. Estensen,et al.  Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. , 1993, Carcinogenesis.

[70]  W F Velicer,et al.  Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[71]  M. Spitz,et al.  Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[72]  J E Henningfield,et al.  Higher levels of nicotine in arterial than in venous blood after cigarette smoking. , 1993, Drug and alcohol dependence.

[73]  J. Minna.  The molecular biology of lung cancer pathogenesis. , 1993, Chest.

[74]  J. Hollis,et al.  Nurse-Assisted Counseling for Smokers in Primary Care , 1993, Annals of Internal Medicine.

[75]  J. Slade,et al.  Nicotine addiction : principles and management , 1993 .

[76]  M C Neale,et al.  Smoking and major depression. A causal analysis. , 1993, Archives of general psychiatry.

[77]  N. Breslau,et al.  Nicotine dependence and major depression. New evidence from a prospective investigation. , 1993, Archives of general psychiatry.

[78]  W. Hong,et al.  The Biology and Prevention of Aerodigestive Tract Cancers , 2012, Advances in Experimental Medicine and Biology.

[79]  T. Baker,et al.  Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. , 1992, Journal of consulting and clinical psychology.

[80]  J. Hughes.  Tobacco withdrawal in self-quitters. , 1992, Journal of consulting and clinical psychology.

[81]  Alan D. Lopez,et al.  Mortality from tobacco in developed countries: indirect estimation from national vital statistics , 1992, The Lancet.

[82]  S. Rodenhuis,et al.  Clinical significance of ras oncogene activation in human lung cancer. , 1992, Cancer research.

[83]  N. Breslau,et al.  Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. , 1992, The American journal of psychiatry.

[84]  L. Joossens,et al.  Steps towards a tobacco advertising ban in the European Community , 1992 .

[85]  M. Fiore,et al.  Trends in cigarette smoking in the United States. The epidemiology of tobacco use. , 1992, The Medical clinics of North America.

[86]  G. Omenn,et al.  Carotene and retinol efficacy trial: lung cancer chemoprevention trial in heavy cigarette smokers and asbestos-exposed workers. CARET Coinvestigators and Staff. , 1992, Advances in experimental medicine and biology.

[87]  N. Breslau,et al.  Nicotine dependence, major depression, and anxiety in young adults. , 1991, Archives of general psychiatry.

[88]  J. Essigmann,et al.  Site-specific mutagenesis: retrospective and prospective. , 1991, Carcinogenesis.

[89]  E H Wagner,et al.  Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program. , 1991, Journal of consulting and clinical psychology.

[90]  N. Benowitz,et al.  Stable isotope studies of nicotine kinetics and bioavailability , 1991, Clinical pharmacology and therapeutics.

[91]  A. Miller,et al.  Cigarette smoking and cancer of the pancreas: Evidence from a population‐based case‐control study in Toronto, Canada , 1991, International journal of cancer.

[92]  R. M. Cruse,et al.  A National Perspective , 1991 .

[93]  Community Intervention Trial for Smoking Cessation (COMMIT): summary of design and intervention. COMMIT Research Group. , 1991, Journal of the National Cancer Institute.

[94]  W. L. Beeson,et al.  History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. , 1990, Journal of the National Cancer Institute.

[95]  M. Fiore,et al.  Methods used to quit smoking in the United States. Do cessation programs help? , 1990, JAMA.

[96]  J. Helzer,et al.  Smoking, smoking cessation, and major depression. , 1990, JAMA.

[97]  P. Remington,et al.  Depression and the dynamics of smoking. A national perspective. , 1990, JAMA.

[98]  T. Pechacek,et al.  A comparison of smoking patterns in the People's Republic of China with the United States. An impending health catastrophe in the middle kingdom. , 1990, JAMA.

[99]  J. Fraumeni,et al.  Renal cancer and cigarette smoking in a 26-year followup of U.S. veterans. , 1990, Public health reports.

[100]  A. Glassman,et al.  Depression and depressive symptoms in smoking cessation. , 1990, Comprehensive psychiatry.

[101]  Michael C. Fiore,et al.  Methods used to quit smoking in the United States. Do cessation programs help , 1990 .

[102]  I. Stolerman,et al.  Nicotine psychopharmacology : molecular, cellular, and behavioural aspects , 1990 .

[103]  S. Hecht,et al.  Advances in Tobacco Carcinogenesis , 1990 .

[104]  D. Hatsukami,et al.  Effects of Abstinence from Tobacco , 1990 .

[105]  T. Baker,et al.  Postcessation cigarette use: the process of relapse. , 1990, Addictive behaviors.

[106]  R. Herning,et al.  Spontaneous EEG changes during tobacco abstinence and nicotine substitution in human volunteers. , 1989, The Journal of pharmacology and experimental therapeutics.

[107]  P Hajek,et al.  Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking , 1989, Psychological Medicine.

[108]  K. Cummings,et al.  Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. , 1989, The American psychologist.

[109]  J. Henningfield,et al.  The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. , 1989, Drug and alcohol dependence.

[110]  T. Svensson,et al.  Pharmacology of nicotine. , 1989, British journal of addiction.

[111]  E. Levin,et al.  Mecamylamine increases nicotine preference and attenuates nicotine discrimination , 1989, Pharmacology Biochemistry and Behavior.

[112]  R. Heidel,et al.  Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General. , 1989 .

[113]  R. West,et al.  Nicotine intake in young smokers: longitudinal study of saliva cotinine concentrations. , 1989, American journal of public health.

[114]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[115]  B. Achinstein,et al.  Journal of the National Cancer Institute, Vol. 29, 1962: Action of bacterial polysaccharide on tumors. II. Damage of sarcoma 37 by serum of mice treated with Serratia marcescens polysaccharide, and induced tolerance. , 2009, Nutrition reviews.

[116]  J. Green.  Heavy Smokers, Smoking Cessation, and Clonidine , 1988 .

[117]  J. Fleiss,et al.  Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. , 1988, JAMA.

[118]  Whitmore Wf.  The treatment of invasive cancers of the bladder , 1988 .

[119]  E. O. O. Smoking.  "The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General" (Title Page through Table of Contents) , 1988 .

[120]  W. Whitmore.  [The treatment of invasive cancers of the bladder]. , 1988, Journal d'urologie.

[121]  G. B. Gori,et al.  Mouth versus deep airways absorption of nicotine in cigarette smokers , 1986, Pharmacology Biochemistry and Behavior.

[122]  S. Hecht,et al.  Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. , 1986, Cancer research.

[123]  L. Bennett.  Research Advances in Alcohol and Drug Problems , 1986 .

[124]  S. Schinke,et al.  Preventing tobacco use among young people. , 1986, Health & social work.

[125]  J. Polivy,et al.  Dieting and binging: A causal analysis. , 1985 .

[126]  C. Pomerleau,et al.  Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation , 1984, Neuroscience & Biobehavioral Reviews.

[127]  S. Shiffman.  Cognitive Antecedents and Sequelae of Smoking Relapse Crises1 , 1984 .

[128]  Polynuclear aromatic compounds, Part 1, Chemical, environmental and experimental data. , 1983, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[129]  Saul Shiffman,et al.  Relapse following smoking cessation: a situational analysis. , 1982, Journal of consulting and clinical psychology.

[130]  S. Hecht,et al.  Assessment of tobacco-specific N-nitrosamines in tobacco products. , 1979, Cancer research.

[131]  A. K. ARMITAGE,et al.  Absorption of Nicotine in Cigarette and Cigar Smoke through the Oral Mucosa , 1970, Nature.

[132]  Education Welfare.,et al.  Smoking and Health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. , 1964 .